Vaxart, Inc. VXRT OTC · Healthcare · United States
$0.36 -4.49% -$0.02
Summary
84 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 16 USD is left as net profit.
- Revenue grew by 1,204% a year over the last 3 years.
- It earns 38 USD a year on every 100 USD of invested capital.
- It holds more cash than debt: $35.1M against $7.22M.
What to watch
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 3.0 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 126% a year over 5 years. Over the last 3 years it grew by 1,204% a year.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 0.7 USD
- Research and development 72 USD
- Sales and administration 10 USD
- Taxes and other 0.6 USD
- Net profit 16 USD
Net profit, industry median (Biotechnology) -11 USD
Out of every 100 USD of revenue, 16 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 3
- Hold 0
- Sell 0
Today's price within the analysts' price targets
The average target of $2 is 452% above today's price. 100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Government Contract 90%
- Collaboration Revenue 6.0%
- License 3.5%
- Non Cash Royalty Revenue 0.8%
By region
The company reports no revenue by region.
Government Contract brings in 90% of revenue. Non Cash Royalty Revenue grew fastest, by 162% a year.
Segments in detail